uric acid has been researched along with arhalofenate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abhishek, A | 1 |
| Choi, YJ; Liu-Bryan, R; Mahata, SK; McWherter, C; Serrano, RL; Terkeltaub, R | 1 |
| Fields, TR | 1 |
| Li, R; Wang, G; Zuo, T | 1 |
2 review(s) available for uric acid and arhalofenate
| Article | Year |
|---|---|
New urate-lowing therapies.
Topics: Acetamides; Drug Interactions; Enzyme Inhibitors; Gout; Gout Suppressants; Humans; Phenylacetates; Probenecid; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents | 2018 |
The Challenges of Approaching and Managing Gout.
Topics: Acetamides; Allopurinol; Antibodies, Monoclonal, Humanized; Colchicine; Diet Therapy; Febuxostat; Gout; Gout Suppressants; Humans; Medication Adherence; Patient Education as Topic; Phenylacetates; Polyethylene Glycols; Quality of Health Care; Rheumatology; Thioglycolates; Triazoles; Urate Oxidase; Uric Acid | 2019 |
2 other study(ies) available for uric acid and arhalofenate
| Article | Year |
|---|---|
Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling.
Topics: Acetamides; AMP-Activated Protein Kinases; Animals; Bone Marrow Cells; Cells, Cultured; Inflammation; Inflammation Mediators; Mice; Mice, Inbred C57BL; Phenylacetates; Signal Transduction; Uric Acid | 2018 |
The mechanism of Arhalofenate in alleviating hyperuricemia-Activating PPARĪ³ thereby reducing caspase-1 activity.
Topics: Acetamides; Anti-Inflammatory Agents; Caspase 1; Cell Line; Cell Survival; Humans; Hyperuricemia; Interleukin-18; Interleukin-1beta; Organic Anion Transporters; Organic Cation Transport Proteins; Phenylacetates; PPAR gamma; Toll-Like Receptor 4; Uric Acid; Uricosuric Agents | 2020 |